Clinical Trial Update: A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MEDI-528 for late asthmatic response in atopic asthma; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI-528

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-11